Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mighty Capital is an active early-stage venture capital firm based in Silicon Valley that invests primarily in B2B technology companies from Seed to Series A. The firm describes its strategy around identifying strong product signals through a large network of product leaders and helping portfolio companies accelerate sales, hiring, and strategic development. While its portfolio includes some digital health, medtech, and life sciences companies, Mighty Capital itself is not a biotech, pharma, or healthcare operating company. It is best categorized as a technology-focused investment firm rather than a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mighty Capital.